title: Hepatoblastoma imaging with gadoxetate disodium-enhanced MRI--typical, atypical, pre- and post-treatment evaluation.
abstract: Gadoxetate disodium (Gd-EOB-DTPA) is a hepatobiliary MRI contrast agent widely used in adults for characterization of liver tumors and increasingly used in children. Hepatoblastoma is the most common primary hepatic malignancy of childhood. In this review, we describe our experience with this agent both before and after initiating therapy in children with hepatoblastoma.
authors.affiliation: Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45219, USA. arthurbmeyers@yahoo.com
authors.forename: Arthur B
authors.initials: AB
authors.lastname: Meyers
authors.forename: Alexander J
authors.initials: AJ
authors.lastname: Towbin
authors.forename: James I
authors.initials: JI
authors.lastname: Geller
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Podberesky
mesh_terms: D000328:Adult; D002648:Child; D002675:Child, Preschool; D003287:Contrast Media; D019786:Gadolinium DTPA; D018197:Hepatoblastoma / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D007223:Infant; D008113:Liver Neoplasms / Q000473:pathology* / Q000628:therapy*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D011379:Prognosis; D016896:Treatment Outcome
chemical_list: D003287:Contrast Media; C073590:gadolinium ethoxybenzyl DTPA; D019786:Gadolinium DTPA